SoftOx Solutions AS (SOFTX) - Net Assets

Latest as of September 2025: Nkr100.26 Million NOK ≈ $10.55 Million USD

Based on the latest financial reports, SoftOx Solutions AS (SOFTX) has net assets worth Nkr100.26 Million NOK (≈ $10.55 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr117.52 Million ≈ $12.37 Million USD) and total liabilities (Nkr17.26 Million ≈ $1.82 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are SoftOx Solutions AS's assets to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets Nkr100.26 Million
% of Total Assets 85.31%
Annual Growth Rate 57.76%
5-Year Change 24.88%
10-Year Change N/A
Growth Volatility 1286.56

SoftOx Solutions AS - Net Assets Trend (2016–2024)

This chart illustrates how SoftOx Solutions AS's net assets have evolved over time, based on quarterly financial data. Also explore SoftOx Solutions AS assets under control for the complete picture of this company's asset base.

Annual Net Assets for SoftOx Solutions AS (2016–2024)

The table below shows the annual net assets of SoftOx Solutions AS from 2016 to 2024. For live valuation and market cap data, see SoftOx Solutions AS stock valuation.

Year Net Assets Change
2024-12-31 Nkr95.18 Million
≈ $10.02 Million
+3922.42%
2023-12-31 Nkr2.37 Million
≈ $249.01K
-85.22%
2022-12-31 Nkr16.01 Million
≈ $1.68 Million
-81.99%
2021-12-31 Nkr88.85 Million
≈ $9.35 Million
+16.57%
2020-12-31 Nkr76.22 Million
≈ $8.02 Million
-11.85%
2019-12-31 Nkr86.47 Million
≈ $9.10 Million
+500.12%
2018-12-31 Nkr14.41 Million
≈ $1.52 Million
-46.33%
2017-12-31 Nkr26.85 Million
≈ $2.83 Million
+982.03%
2016-12-31 Nkr2.48 Million
≈ $261.08K
--

Equity Component Analysis

This analysis shows how different components contribute to SoftOx Solutions AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock Nkr39.03 Million 41.00%
Other Components Nkr56.16 Million 59.00%
Total Equity Nkr95.18 Million 100.00%

SoftOx Solutions AS Competitors by Market Cap

The table below lists competitors of SoftOx Solutions AS ranked by their market capitalization.

Company Market Cap
Mindax Ltd
AU:MDX
$30.10 Million
Lung Hwa Electronics Co Ltd
TW:2424
$30.11 Million
AQUA SA ZY 16
F:9S0
$30.13 Million
nTels Co. Ltd
KQ:069410
$30.13 Million
Kein Hing International Bhd
KLSE:7199
$30.08 Million
9F Inc
NASDAQ:JFU
$30.07 Million
Senetas Corporation Ltd
AU:SEN
$30.03 Million
Next Science Ltd
AU:NXS
$30.02 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in SoftOx Solutions AS's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,366,350 to 95,184,540, a change of 92,818,190 (3922.4%).
  • Net loss of 42,944,430 reduced equity.
  • Share repurchases of 35,744,560 reduced equity.
  • New share issuances of 35,744,555 increased equity.
  • Other factors increased equity by 135,762,625.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Nkr-42.94 Million -45.12%
Share Repurchases Nkr35.74 Million -37.55%
Share Issuances Nkr35.74 Million +37.55%
Other Changes Nkr135.76 Million +142.63%
Total Change Nkr- 3922.42%

Book Value vs Market Value Analysis

This analysis compares SoftOx Solutions AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.45x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.18x to 2.45x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 Nkr0.66 Nkr0.12 x
2017-12-31 Nkr7.07 Nkr0.12 x
2018-12-31 Nkr3.81 Nkr0.12 x
2019-12-31 Nkr11.16 Nkr0.12 x
2020-12-31 Nkr9.15 Nkr0.12 x
2021-12-31 Nkr8.59 Nkr0.12 x
2022-12-31 Nkr1.55 Nkr0.12 x
2023-12-31 Nkr0.06 Nkr0.12 x
2024-12-31 Nkr0.05 Nkr0.12 x

Capital Efficiency Dashboard

This dashboard shows how efficiently SoftOx Solutions AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -45.12%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -542.64%
  • • Asset Turnover: 0.07x
  • • Equity Multiplier: 1.27x
  • Recent ROE (-45.12%) is above the historical average (-299.67%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -250.51% -6153.87% 0.01x 3.57x Nkr-6.46 Million
2017 -35.04% -940827.00% 0.00x 1.16x Nkr-12.09 Million
2018 -89.73% -299.06% 0.18x 1.62x Nkr-14.37 Million
2019 -18.89% -398.54% 0.04x 1.21x Nkr-24.98 Million
2020 -49.08% -380.17% 0.11x 1.15x Nkr-45.03 Million
2021 -97.12% -1092.14% 0.07x 1.21x Nkr-95.17 Million
2022 -444.47% -1000.07% 0.09x 4.86x Nkr-72.74 Million
2023 -1667.07% -565.17% 0.07x 41.09x Nkr-39.69 Million
2024 -45.12% -542.64% 0.07x 1.27x Nkr-52.46 Million

Industry Comparison

This section compares SoftOx Solutions AS's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $152,223,456
  • Average return on equity (ROE) among peers: -81.29%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
SoftOx Solutions AS (SOFTX) Nkr100.26 Million -250.51% 0.17x $30.08 Million
Arcticzymes Technologies ASA (AZT) $323.35 Million 2.62% 0.06x $107.48 Million
Bergenbio ASA (BGBIO) $12.05 Million 0.00% 0.48x $7.75 Million
Circio Holding ASA (CRNA) $-12.49 Million 0.00% 0.00x $232.03 Million
Exact Therapeutics AS (EXTX) $57.06 Million -13.29% 0.11x $9.79 Million
Lytix Biopharma AS (LYTIX) $61.75 Million -97.14% 0.32x $87.39 Million
Nykode Therapeutics ASA (NYKD) $140.07 Million -45.54% 0.09x $112.54 Million
Oncoinvent ASA (ONCIN) $384.43 Million -80.47% 0.17x $21.91 Million
PCI Biotech Holding ASA (PCIB) $339.95 Million -10.23% 0.05x $274.95K
Thor Medical ASA (TRMED) $63.84 Million -487.52% 0.72x $168.29 Million

About SoftOx Solutions AS

OL:SOFTX Norway Biotechnology
Market Cap
$30.08 Million
Nkr285.89 Million NOK
Market Cap Rank
#23793 Global
#220 in Norway
Share Price
Nkr0.12
Change (1 day)
-8.00%
52-Week Range
Nkr0.05 - Nkr0.16
All Time High
Nkr112.00
About

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more